Safety of Thiopurine Use in Paediatric Gastrointestinal Disease-Reference-Cited by-同舟云学术

Safety of Thiopurine Use in Paediatric Gastrointestinal Disease

Published:2020-06-09 Issue:2 Volume:71 Page:156-162
ISSN:0277-2116
Container-title:Journal of Pediatric Gastroenterology & Nutrition
language:en
Short-container-title:

Author:

Miele Erasmo,Benninga Marc A.,Broekaert Ilse,Dolinsek Jernej,Mas Emmanuel,Orel Rok,Pienar Corina,Ribes-Koninckx Carmen,Thomassen Rut A.,Thomson Mike,Tzivinikos Christos,Thapar Nikhil

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Pediatrics, Perinatology, and Child Health

Reference70 articles.

1. Therapeutic drug monitoring in pediatric IBD: current application and future perspectives;Lega;Curr Med Chem,2018

2. Clinical pharmacology and pharmacogenetics of thiopurines;Sahasranaman;Eur J Clin Pharmacol,2008

3. Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease;Hyams;Gastroenterology,2017

4. Thiopurine monotherapy in pediatric inflammatory bowel disease: 20 years after Markowitz;Wilson;J Pediatr Gastroenterol Nutr,2020

5. The role of thiopurine metabolite monitoring in inflammatory bowel disease;Beswick;Expert Rev Gastroenterol Hepatol,2014

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of anemia in pediatric inflammatory bowel diseases: Clinical practice guidelines on behalf of the SIGENP IBD Working group;Digestive and Liver Disease;2024-08

2. Drug‐Related Adverse Reactions in Pediatric Inflammatory Bowel Disease;The Journal of Clinical Pharmacology;2023-09-09

3. Mercaptopurine Therapy;Pediatric Inflammatory Bowel Disease;2023